AKT1 and esophageal squamous cell carcinoma: Likewise, our kinase inhibition study found that, in our circumstance, phosphorylation of AKT on Ser473 attenuated after treating with specific inhibitor cpd22 in a dose-depended manner, resulting in suppressed proliferation and blocked invasion of ESCC cells.